rp OTCMKTS:PXXLF - Stock Price, News, & Analysis for Poxel

OTCMKTS:PXXLF - Poxel Stock Price, News, & Analysis

0.00 (0.00 %)
(As of 06/17/2019 01:14 PM ET)
Today's Range
Now: $7.70
50-Day Range
MA: $7.96
52-Week Range
Now: $7.70
Average Volume244 shs
Market Capitalization$189.11 million
P/E Ratio12.22
Dividend YieldN/A
Poxel SA, a biopharmaceutical company, develops drugs for metabolic diseases with a primary focus on type II diabetes. Its lead product is Imeglimin, an oral anti-diabetic candidate, which is in Phase III clinical development stage that targets the organs of diabetes, such as pancreas, liver, and muscles. The company is also developing PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in Phase IIa clinical trial that controls body energy metabolism and treats chronic metabolic diseases, such as non-alcoholic steatohepatitis. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations



Sales & Book Value

Annual Sales$88.11 million
Cash Flow$0.6343 per share
Book Value$2.68 per share



Market Cap$189.11 million
Next Earnings Date6/20/2019 (Estimated)
OptionableNot Optionable

Receive PXXLF News and Ratings via Email

Sign-up to receive the latest news and ratings for PXXLF and its competitors with MarketBeat's FREE daily newsletter.

Poxel (OTCMKTS:PXXLF) Frequently Asked Questions

What is Poxel's stock symbol?

Poxel trades on the OTCMKTS under the ticker symbol "PXXLF."

How were Poxel's earnings last quarter?

Poxel SA (OTCMKTS:PXXLF) announced its quarterly earnings data on Thursday, March, 21st. The company reported $10.04 EPS for the quarter. The company had revenue of $88.11 million for the quarter. View Poxel's Earnings History.

When is Poxel's next earnings date?

Poxel is scheduled to release their next quarterly earnings announcement on Thursday, June 20th 2019. View Earnings Estimates for Poxel.

Has Poxel been receiving favorable news coverage?

News articles about PXXLF stock have been trending somewhat positive on Monday, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Poxel earned a media sentiment score of 1.4 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for Poxel.

Who are some of Poxel's key competitors?

What other stocks do shareholders of Poxel own?

Who are Poxel's key executives?

Poxel's management team includes the folowing people:
  • Mr. Thomas Kuhn Pharm D MBA, Co-Founder, CEO & Director
  • Mr. Sébastien Bolze Pharm D Ph.D., Co-Founder, Exec. VP of Non Clinical Devel. and Scientific Director
  • Ms. Pascale Fouqueray-Grellier, Co-Founder & Exec. VP of Early Devel. & Translational Medicine
  • Ms. Sophie Hallakou-Bozec, Co-Founder & Sr. VP of R&D Pharmacology
  • Ms. Anne Renevot, CFO & Director of Fin.s

How do I buy shares of Poxel?

Shares of PXXLF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Poxel's stock price today?

One share of PXXLF stock can currently be purchased for approximately $7.70.

How big of a company is Poxel?

Poxel has a market capitalization of $189.11 million and generates $88.11 million in revenue each year. The company earns $15.97 million in net income (profit) each year or $0.63 on an earnings per share basis. Poxel employs 33 workers across the globe.View Additional Information About Poxel.

MarketBeat Community Rating for Poxel (OTCMKTS PXXLF)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  42 (Vote Outperform)
Underperform Votes:  52 (Vote Underperform)
Total Votes:  94
MarketBeat's community ratings are surveys of what our community members think about Poxel and other stocks. Vote "Outperform" if you believe PXXLF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PXXLF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/17/2019 by MarketBeat.com Staff

Featured Article: What is a bull market?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel